Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Open accessThe DOI matches its Crossref record; 397 of the 397 references it cites were found in a registry or an index.
Abstract
Rheumatoid arthritis (RA) is an incurable systemic autoimmune disease. Disease progression leads to joint deformity and associated loss of function, which significantly impacts the quality of life for sufferers and adds to losses in the labor force. In the past few decades, RA has attracted increased attention from researchers, the abnormal signaling pathways in RA are a very important research field in the diagnosis and treatment of RA, which provides important evidence for understanding this complex disease and developing novel RA-linked intervention targets. The current review intends to provide a comprehensive overview of RA, including a general introduction to the disease, historical events, epidemiology, risk factors, and pathological process, highlight the primary research progress of the disease and various signaling pathways and molecular mechanisms, including genetic factors, epigenetic factors, summarize the most recent developments in identifying novel signaling pathways in RA and new inhibitors for treating RA. therapeutic interventions including approved drugs, clinical drugs, pre-clinical drugs, and cutting-edge therapeutic technologies. These developments will hopefully drive progress in new strategically targeted therapies and hope to provide novel ideas for RA treatment options in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–397 of 397
Furneri, G., Mantovani, L. G., Belisari, A., Mosca, M., Cristiani, M., Bellelli, S., Cortesi, P. A., & Turchetti, G. (2012) · PubMed · Cited by 129
Angiogenesis as a potential treatment strategy for rheumatoid arthritis
Wang, Y., Wu, H., & Deng, R. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174500 · Cited by 129
Ba, X., Huang, Y., Shen, P., Huang, Y., Wang, H., Han, L., Lin, W., Yan, H., Xu, L. J., Qin, K., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.696802 · Cited by 129
Genovese, M. C., van Vollenhoven, R. F., Pacheco‐Tena, C., Zhang, Y., & Kinnman, N. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39473 · Cited by 128
Cellular and molecular perspectives in rheumatoid arthritis
Veale, D. J., Orr, C. K., & Fearon, U. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0633-1 · Cited by 126
miRNA-146a Improves Immunomodulatory Effects of MSC-derived Exosomes in Rheumatoid Arthritis
Tavasolian, F., Hosseini, A. Z., Soudi, S., & Naderi, M. (2020) · Current Gene Therapy · doi:10.2174/1566523220666200916120708 · Cited by 125
Philippe, L., Alsaleh, G., Pichot, A., Ostermann, E., Zuber, G., Frisch, B., Sibilia, J., Pfeffer, S., Bahram, S., Wachsmann, D., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201654 · Cited by 124
Cohen, S., Tuckwell, K., Katsumoto, T. R., Zhao, R., Galanter, J., Lee, C., Rae, J., Toth, B., Ramamoorthi, N., Hackney, J. A., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41275 · Cited by 123
Cardiovascular disease in patients with rheumatoid arthritis
Liao, K. P. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.07.006 · Cited by 121
Rains, C. P., Noble, S., & Faulds, D. M. (1995) · Drugs · doi:10.2165/00003495-199550010-00009 · Cited by 119
Fechtner, S., Singh, A., Chourasia, M., & Ahmed, S. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.05.016 · Cited by 116
Maes, T., Barceló, A., & Buesa, C. (2002) · Genomics · doi:10.1006/geno.2002.6799 · Cited by 115
Lee, S.-Y., Kwok, S., Son, H., Ryu, J., Kim, E., Oh, H., Cho, M., Ju, J. H., Park, S., & Kim, H. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4179 · Cited by 115
Hannemann, N., Cao, S., Eriksson, D., Schnelzer, A., Jordan, J., Eberhardt, M., Schleicher, U., Rech, J., Ramming, A., Uebe, S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci96832 · Cited by 115
Expression and Function of Histone Deacetylases in Rheumatoid Arthritis Synovial Fibroblasts
HORIUCHI, M., MORINOBU, A., CHIN, T., SAKAI, Y., KUROSAKA, M., & KUMAGAI, S. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081115 · Cited by 114
mTOR Regulates the Invasive Properties of Synovial Fibroblasts in Rheumatoid Arthritis
Laragione, T., & Gulko, P. S. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00049 · Cited by 111
RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression
Meyer zu Horste, G., Wu, C., Wang, C., Cong, L., Pawlak, M., Lee, Y., Elyaman, W., Xiao, S., Regev, A., & Kuchroo, V. K. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.088 · Cited by 111
Diagnosis of Early Rheumatoid Arthritis: what the Non-Specialist Needs to Know
Suresh, E. (2004) · Journal of the Royal Society of Medicine · doi:10.1177/014107680409700903 · Cited by 111
Coutant, F., & Miossec, P. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000664 · Cited by 109
Singh, D., Smyth, L. J. C., Borrill, Z., Sweeney, L. M., & Tal‐Singer, R. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009347873 · Cited by 108
Samarpita, S., Kim, J. Y., Rasool, M., & Kim, K. S. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-2097-2 · Cited by 108
MicroRNA regulation of lymphocyte tolerance and autoimmunity
Simpson, L. J., & Ansel, K. M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78090 · Cited by 106
Imbalance of circulating Tfr/Tfh ratio in patients with rheumatoid arthritis
Wang, X., Yang, C., Xu, F. H., Qi, L., Wang, J., & Yang, P. (2018) · Clinical and Experimental Medicine · doi:10.1007/s10238-018-0530-5 · Cited by 106
Dai, Y., Wang, W., Yu, Y., & Hu, S. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05320-z · Cited by 102
Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts
Baum, R., & Gravallese, E. M. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8515-6 · Cited by 101
Brody, M., Böhm, I., & Bauer, R. (1993) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1993.31.10.667 · Cited by 101
Sarilumab: A Review in Moderate to Severe Rheumatoid Arthritis
Lamb, Y. N., & Deeks, E. D. (2018) · Drugs · doi:10.1007/s40265-018-0929-z · Cited by 100
Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis.
Pargellis, C., & Regan, J. R. (2003) · PubMed · Cited by 99
Blaszczyk, K., Olejnik, A., Nowicka, H., Ozgyin, L., Chen, Y.-L., Chmielewski, S., Kostyrko, K., Wesoly, J., Balint, B. L., Lee, C.-K., et al. (2015) · Biochemical Journal · doi:10.1042/bj20140644 · Cited by 98
Corvetta, A., Bitta, R. D., Luchetti, M. M., & Pomponio, G. (1991) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(91)80265-e · Cited by 98
Keewan, E., & Naser, S. A. (2020) · Cells · doi:10.3390/cells9010111 · Cited by 98
Dale, J. E., Alcorn, N., Capell, H. A., et al. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0562 · Cited by 96
Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms
Muller, S., & Radic, M. Z. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8459-2 · Cited by 95
MicroRNA-124 inhibits the progression of adjuvant-induced arthritis in rats
Nakamachi, Y., Ohnuma, K., Uto, K., Noguchi, Y., Saegusa, J., & Kawano, S. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206417 · Cited by 95
Inhibition of Notch signalling ameliorates experimental inflammatory arthritis
Park, J., Kim, S.-H., Kim, K., Jin, C., Choi, K. Y., Jang, J., Choi, Y., Gwon, A., Baik, S., Yun, U. J., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203467 · Cited by 95
Preclinical rheumatoid arthritis and rheumatoid arthritis prevention
Greenblatt, H. K., Kim, H., Bettner, L. F., & Deane, K. D. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000708 · Cited by 95
Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs)
Saraswat, A. L., Vartak, R., Hegazy, R. R., Patel, A., & Patel, K. R. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103387 · Cited by 92
MAPK-Activated Protein Kinases (MKs): Novel Insights and Challenges
Gaestel, M. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00088 · Cited by 91
Grabiec, A. M., Tak, P. P., & Reedquist, K. A. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2489 · Cited by 90
Management issues in rheumatoid arthritis-associated interstitial lung disease
England, B. R., & Hershberger, D. M. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000703 · Cited by 89
Wu, W., Jia, W., Liu, X., Pan, L., Zhang, Q.-Y., Yang, D., Shen, X., Liu, L., & Zhu, Y. Z. (2016) · Redox Biology · doi:10.1016/j.redox.2016.08.011 · Cited by 87
Self-citationOsteoporosis and fractures in rheumatoid arthritis
Wysham, K. D., Baker, J. F., & Shoback, D. (2021) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000789 · Cited by 87
Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes.
Umetsu, D. T., Katzen, D., Jabara, H. H., & Geha, R. S. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.2.440 · Cited by 86
Dhillon, S., & Keam, S. J. (2020) · Drugs · doi:10.1007/s40265-020-01439-0 · Cited by 86
Sun, J., Yan, P., Chen, Y., Chen, Y., Jian-xun, Y., Xu, G., Mao, H., & Qiu, Y. (2015) · Diagnostic Pathology · doi:10.1186/s13000-015-0309-x · Cited by 85
Fu, L., Ma, C., Cong, B., Li, S., Chen, H., & Zhang, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.98 · Cited by 84
The Wnt signaling pathway and rheumatoid arthritis
Rabelo, F. D. S., da Mota, L. M. H., Lima, R. A. C., Lima, F. A. C., Barra, G. B., de Carvalho, J. F., & Amato, A. A. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.08.003 · Cited by 84
Stump, K. L., Lu, L. D., Dobrzański, P., Serdikoff, C., Gingrich, D. E., Dugan, B. J., Angeles, T. S., Albom, M. S., Ator, M. A., Dorsey, B. D., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3329 · Cited by 84
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Zhao, S. S., Chadwick, L., Mysler, E., & Moots, R. J. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0769-6 · Cited by 84
Wu, W., Qin, M., Jia, W., Huang, Z., Li, Z., Yang, D., Huang, M., Xiao, C., Long, F., Mao, J., et al. (2018) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0037-8 · Cited by 83
Self-citationBurden of rheumatoid arthritis on patients’ work productivity and quality of life
Xavier, R. M., Zerbini, C. A. F., Pollak, D. F., Morales‐Torres, J., Chalem, P., Restrepo, J. F. M., Duhau, J. A., Amado, J. R., Abello, M., la Vega, M. C. D., et al. (2019) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-019-0090-8 · Cited by 82
Ju, J. H., Heo, Y., Cho, M., Jhun, J., Park, J., Lee, S.-Y., Oh, H., Moon, S., Kwok, S., Park, K., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34601 · Cited by 80
Jiao, Z., Wang, W., Ma, J., Wang, S., Su, Z., & Xu, H. (2011) · Clinical and Developmental Immunology · doi:10.1155/2012/350209 · Cited by 80
Liver involvement in subjects with rheumatic disease
Selmi, C. F., Santis, M. D., & Gershwin, M. E. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3319 · Cited by 80
Stat3 as a potential therapeutic target for rheumatoid arthritis
Oike, T., Sato, Y., Kobayashi, T., Miyamoto, K., Nakamura, S., Kaneko, Y., Kobayashi, S., Harato, K., Saya, H., Matsumoto, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11233-w · Cited by 80
The atRA‐responsive gene neuron navigator 2 functions in neurite outgrowth and axonal elongation
Muley, P. D., McNeill, E. M., Marzinke, M. A., Knobel, K. M., Barr, M. M., & Clagett‐Dame, M. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20670 · Cited by 79
How does abatacept really work in rheumatoid arthritis?
Bonelli, M. M., & Scheinecker, C. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000491 · Cited by 79
Recent Advances in BTK Inhibitors for the Treatment of Inflammatory and Autoimmune Diseases
Zhang, D., He, G., & Meng, F. (2021) · Molecules · doi:10.3390/molecules26164907 · Cited by 79
Weyand, C. M., & Goronzy, J. J. (2000) · Arthritis Research · doi:10.1186/ar90 · Cited by 78
Epigenetic Alterations in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
Doody, K. M., Bottini, N., & Firestein, G. S. (2017) · Epigenomics · doi:10.2217/epi-2016-0151 · Cited by 78
Rheumatoid arthritis and risk of cardiovascular disease
Meyer, P. W. A., Anderson, R., Ker, J. A., & Ally, M. M. T. M. (2018) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2018-018 · Cited by 78
Selective Tyk2 inhibitors as potential therapeutic agents: a patent review (2015–2018)
He, X., Chen, X., Zhang, H., Xie, T., & Ye, X. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1567713 · Cited by 78
Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease
Rip, J., de Bruijn, M. J. W., Appelman, M. K., Pal Singh, S., Hendriks, R. W., & Corneth, O. B. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00095 · Cited by 77
Oh, B. R., Suh, D., Bae, D., Ha, N., Choi, Y. I., Yoo, H. J., Park, J. K., Lee, E. Y., Lee, E. B., & Song, Y. W. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1357-2 · Cited by 76
Upadacitinib for the treatment of rheumatoid arthritis
Serhal, L., & Edwards, C. J. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1544892 · Cited by 76
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations
de Araujo, E. D., Orlova, A., Neubauer, H. A., Bajusz, D., Seo, H., Dhe‐Paganon, S., Keserű, G. M., Moriggl, R., & Gunning, P. T. (2019) · Cancers · doi:10.3390/cancers11111757 · Cited by 76
Sulfasalazine for treating rheumatoid arthritis
Suarez-Almazor, M. E., Belseck, E., Shea, B., Tugwell, P., & Wells, G. A. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000958 · Cited by 75
Hot, A., Zrioual, S., Toh, M., Lenief, V., & Miossec, P. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.132233 · Cited by 75
Role of notch-1 intracellular domain in activation of rheumatoid synoviocytes
Nakazawa, M., Ishii, H., Aono, H., Takai, M., Honda, T., Aratani, S., Fukamizu, A., Nakamura, H., Yoshino, S., Kobata, T., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1545::aid-art278>3.0.co;2-q · Cited by 74
Hu, H., Luan, L., Yang, K., & Li, S. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13028 · Cited by 74
Renal Manifestations of Rheumatoid Arthritis
Kapoor, T. M., & Bathon, J. M. (2018) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2018.06.008 · Cited by 74
Smith, C. I. E., & Burger, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.689472 · Cited by 74
Clinical connection between rheumatoid arthritis and liver damage
Dinić, B. R. , Tešić-Rajković, S., Zivkovic, V. G., & Grgov, S. (2018) · Rheumatology International · doi:10.1007/s00296-018-4021-5 · Cited by 73
JAK / STAT signaling in regulation of innate lymphoid cells: The gods before the guardians
Stabile, H., Scarno, G., Fionda, C., Gismondi, A., Santoni, A., Gadina, M., & Sciumè, G. (2018) · Immunological Reviews · doi:10.1111/imr.12705 · Cited by 73
Golimumab for rheumatoid arthritis
Singh, J. A., Noorbaloochi, S., & Singh, G. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008341 · Cited by 72
Hussain, M. S., & Tripathi, V. (2018) · Military Medical Research · doi:10.1186/s40779-018-0158-5 · Cited by 72
Jia, W., Wu, W., Yang, D., Xiao, C., Su, Z., Huang, Z., Li, Z., Qin, M., Huang, M., Liu, S., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701483r · Cited by 71
Self-citationTargeting Histone Deacetylases: A Novel Approach in Parkinson’s Disease
Sharma, S., & Taliyan, R. (2015) · Parkinson's Disease · doi:10.1155/2015/303294 · Cited by 70
Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation
Jones, D. S., Jenney, A., Swantek, J. L., Burke, J. M., Lauffenburger, D. A., & Sorger, P. K. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2211 · Cited by 70
Singh, A., Patro, P. S., & Aggarwal, A. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4380-z · Cited by 70
Anakinra: A Review of its Use in the Management of Rheumatoid Arthritis
Waugh, J., & Perry, C. M. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00005 · Cited by 69
Role of Nrf2 in rheumatoid arthritis
Chadha, S., Behl, T., Kumar, A., Khullar, G., & Arora, S. (2020) · Current Research in Translational Medicine · doi:10.1016/j.retram.2020.05.002 · Cited by 69
Lu, X., Hu, R., Peng, L., Liu, M., & Sun, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638444 · Cited by 69
A review of upadacitinib in rheumatoid arthritis
Tanaka, Y. (2020) · Modern Rheumatology · doi:10.1080/14397595.2020.1782049 · Cited by 68
Infliximab treatment of rheumatoid arthritis
Maini, S. R. N. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.01.009 · Cited by 67
Abatacept for the treatment of rheumatoid arthritis
Pombo‐Suárez, M., & Gómez-Reino, J. J. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1579642 · Cited by 67
Jmjd1c demethylates STAT3 to restrain plasma cell differentiation and rheumatoid arthritis
Yin, Y., Yang, X., Wu, S., Ding, X., Zhu, H., Long, X., Wang, Y., Zhai, S., Chen, Y., Che, N., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01287-y · Cited by 67
Maracle, C. X., Kucharzewska, P., Helder, B., van der Horst, C., de Sampaio, P. C., Noort, A.-R., van Zoest, K. P. M., Griffioen, A. W., Olsson, H., & Tas, S. W. (2016) · Rheumatology · doi:10.1093/rheumatology/kew393 · Cited by 66
Mahajan, S., Hogan, J. K., Shlyakhter, D., Oh, L., Salituro, F. G., Farmer, L. J., & Hoock, T. C. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221176 · Cited by 65
Ahmad, S. F., Ansari, M. A., Nadeem, A., Zoheir, K. M. A., Bakheet, S. A., Alsaad, A. M. S., Al‐Shabanah, O. A., & Attia, S. M. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.10.001 · Cited by 64
Pathogenesis and treatment of autoimmune rheumatic diseases
Liu, E. V., & Perl, A. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000594 · Cited by 63
Coy, J. F., Wiemann, S., Bechmann, I., Bächner, D., Nitsch, R., Kretz, O., Christiansen, H., & Poustka, A. (2002) · Gene · doi:10.1016/s0378-1119(02)00567-x · Cited by 62
Wang, F., Sengupta, T. K., Zhong, Z., & Ivashkiv, L. B. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1825 · Cited by 62
Nav2 is necessary for cranial nerve development and blood pressure regulation
McNeill, E. M., Roos, K. P., Moechars, D., & Clagett‐Dame, M. (2010) · Neural Development · doi:10.1186/1749-8104-5-6 · Cited by 62
GATA4 regulates angiogenesis and persistence of inflammation in rheumatoid arthritis
Jia, W., Wu, W., Yang, D., Xiao, C., Huang, M., Long, F., Su, Z., Qin, M., Liu, X., & Zhu, Y. Z. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0570-5 · Cited by 61
Self-citationA Fast and Clean BTK Inhibitor
Gabizon, R., & London, N. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00597 · Cited by 61
MiR‐146a levels in rheumatoid arthritis and their correlation with disease activity: a meta‐analysis
Bae, S., & Lee, Y. H. (2018) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13338 · Cited by 60
Real-world experience with tofacitinib for the treatment of rheumatoid arthritis.
Caporali, R. F., & Zavaglia, D. (2019) · PubMed · Cited by 60
ERK Inhibitors as a Potential New Therapy for Rheumatoid Arthritis
Ohori, M. (2008) · Drug News & Perspectives · doi:10.1358/dnp.2008.21.5.1219006 · Cited by 59
Effect of Moxibustion on HIF-1α and VEGF Levels in Patients with Rheumatoid Arthritis
Gong, Y., Yu, Z., Wang, Y., Xiong, Y., Zhou, Y., Liao, C., Li, Y., Luo, Y., Bai, Y. Z., Chen, B., et al. (2019) · Pain Research and Management · doi:10.1155/2019/4705247 · Cited by 58
Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritis
Göschl, L., Preglej, T., Boucheron, N., Saferding, V., Müller, L., Platzer, A., Hirahara, K., Shih, H., Bäcklund, J., Matthias, P., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102379 · Cited by 58
Monari, C., Bevilacqua, S., Piccioni, M., Pericolini, E., Perito, S., Calvitti, M., Bistoni, F., Kozel, T. R., & Vecchiarelli, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804144 · Cited by 57
Shoda, H., Nagafuchi, Y., Tsuchida, Y., Sakurai, K., Sumitomo, S., Fujio, K., & Yamamoto, K. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1308-y · Cited by 57
Chakrabarti, S., Hore, Z. L., Pattison, L. A., Lalnunhlimi, S., Bhebhe, C. N., Callejo, G., Bulmer, D. C., Taams, L. S., Denk, F., & Smith, E. S. J. (2020) · Pain · doi:10.1097/j.pain.0000000000001890 · Cited by 57
Liu, C., Lin, J., Wrobleski, S. T., Lin, S., Hynes, J., Wu, H., Dyckman, A. J., Li, T., Wityak, J., Gillooly, K. M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100540x · Cited by 56
MicroRNAs and bioactive compounds on TLR/MAPK signaling in rheumatoid arthritis
Sujitha, S., & Rasool, M. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.08.021 · Cited by 56
Abbasifard, M., Imani, D., & Bagheri‐Hosseinabadi, Z. (2020) · The Journal of Gene Medicine · doi:10.1002/jgm.3204 · Cited by 56
Park, J. K., Jang, Y. J., Oh, B. R., Shin, J., Bae, D., Ha, N., Choi, Y. I., Youn, G. S., Park, J., Lee, E. Y., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02258-0 · Cited by 56
Ha, Y., Lee, S., Mun, C. H., Kim, H. J., Bae, Y., Lim, J.-H., Park, K.-H., Lee, S.-K., Yoo, K., & Park, Y. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02230-y · Cited by 55
Emori, T., Kasahara, M., Sugahara, S., Hashimoto, M., Ito, H., Narumiya, S., Higashi, Y., & Fujii, Y. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173238 · Cited by 55
Wu, H., Yan, S., Chen, J., Luo, X., Li, P., Jia, X., Dai, X., Wang, C., Huang, Q., Liu, L., et al. (2016) · Joint Bone Spine · doi:10.1016/j.jbspin.2015.09.002 · Cited by 52
Genovese, M. C., Yang, F., Østergaard, M., & Kinnman, N. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208901 · Cited by 52
Darnowski, J. W., Goulette, F. A., Guan, Y. A., Chatterjee, D., Yang, Z., Cousens, L. P., & Chin, Y. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600088200 · Cited by 51
Azer, S. A., AlSwaidan, N., Alshwairikh, L., & AlShammari, J. M. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008187 · Cited by 51
Dinesh, P., & Rasool, M. (2018) · Cytokine · doi:10.1016/j.cyto.2018.03.005 · Cited by 51
Notch1 Signaling Regulates the Th17/Treg Immune Imbalance in Patients with Psoriasis Vulgaris
Ma, L., Xue, H., Gao, T., Gao, M., & Zhang, Y. (2018) · Mediators of Inflammation · doi:10.1155/2018/3069521 · Cited by 51
Kim, T., Choi, S. J., Lee, Y. H., Song, G. G., & Ji, J. D. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.022 · Cited by 50
Patel, L., Chandrasekhar, J., Evarts, J., Forseth, K., Haran, A. C., Ip, C., Kashishian, A., Kim, M., Koditek, D., Koppenol, S., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01169 · Cited by 50
Molendijk, M., Hazes, J. M., & Lubberts, E. (2018) · RMD Open · doi:10.1136/rmdopen-2016-000256 · Cited by 50
A genome-engineered bioartificial implant for autoregulated anticytokine drug delivery
Choi, Y., Collins, K. H., Springer, L. E., Pferdehirt, L., Ross, A. K., Wu, C., Moutos, F. T., Harasymowicz, N. S., Brunger, J. M., Pham, C. T. N., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj1414 · Cited by 50
MAPK phosphatases as novel targets for rheumatoid arthritis
Ralph, J. A., & Morand, E. F. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.7.795 · Cited by 49
ElAtta, A. S. A., Ali, Y. B. M., Bassyouni, I. H., & Talaat, R. M. (2018) · Clinical and Experimental Medicine · doi:10.1007/s10238-018-0524-3 · Cited by 48
Wang, Y., Feng, T., Duan, S., Shi, Y., Li, S., Zhang, X., & Zhang, L. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8330 · Cited by 48
Follicular helper T cells: potential therapeutic targets in rheumatoid arthritis
Lu, J., Wu, J., Xia, X., Peng, H., & Wang, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03839-1 · Cited by 48
CD90+ Stromal Cells are Non-Professional Innate Immune Effectors of the Human Colonic Mucosa
Owens, B. M. J., Steevels, T. A. M., Dudek, M., Walcott, D., Sun, M., Mayer, A., Allan, P., & Simmons, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00307 · Cited by 47
Toyama, S., Tamura, N., Haruta, K., Karakida, T., Mori, S., Watanabe, T., Yamori, T., & Takasaki, Y. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3019 · Cited by 47
Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis
Arneson, L. C., Carroll, K., & Ruderman, E. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s288550 · Cited by 47
Hsieh, I.-N., Liou, J.-P., LEE, H. Y., Lai, M.-J., Li, Y.-H., & Yang, C.-R. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.133 · Cited by 45
The ascent of acetylation in the epigenetics of rheumatoid arthritis
Grabiec, A. M., & Reedquist, K. A. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.17 · Cited by 44
Tsai, C., Liu, S., Wang, Y., Su, C., Huang, C., Hsu, C., & Tang, C. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.11.015 · Cited by 44
Zhang, W., Zhang, X., Sheng, A., Weng, C., Zhu, T., Zhao, W., & Li, C. (2015) · Mediators of Inflammation · doi:10.1155/2015/258168 · Cited by 42
Ahmed, S., Riegsecker, S., Beamer, M. A., Rahman, A., Bellini, J. V., Bhansali, P. R., & Tillekeratne, L. M. V. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.04.014 · Cited by 42
Pre-rheumatoid arthritis and its prevention
Paul, B. J., Kandy, H. I., & Krishnan, V. (2017) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2017.16006 · Cited by 42
Rossignol, S. L., Ketheesan, N., & Haleagrahara, N. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1363198 · Cited by 42
The liver in rheumatic diseases
Weinblatt, M. E., Tesser, J., & Gilliam, J. H. (1982) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(82)90027-0 · Cited by 41
HLA Polymorphisms and T Cells in Rheumatoid Arthritis
Weyand, C. M., & Goronzy, J. J. (1999) · International Reviews of Immunology · doi:10.3109/08830189909043018 · Cited by 41
Joint Location–Specific JAK ‐ STAT Signaling in Rheumatoid Arthritis Fibroblast‐like Synoviocytes
Hammaker, D. R., Nygaard, G., Kuhs, A., Ai, R., Boyle, D. L., Wang, W., & Firestein, G. S. (2019) · ACR Open Rheumatology · doi:10.1002/acr2.11093 · Cited by 41
MeCP2 Regulates PTCH1 Expression Through DNA Methylation in Rheumatoid Arthritis
Sun, Z., Liu, Y., Liu, J., Xu, D., Li, X., Meng, X., Ma, T., Huang, C., & Li, J. (2017) · Inflammation · doi:10.1007/s10753-017-0591-8 · Cited by 40
MicroRNA-146a protects against LPS-induced organ damage by inhibiting Notch1 in macrophage
Bai, X., Zhang, J., Cao, M., Han, S., Yang, L., Wang, K., Han, F., Li, X., Jia, Y., Wang, X., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.07.040 · Cited by 40
The impact of rheumatoid arthritis on the burden of disease in urban China
Langley, P. C., Mu, R., Michael Shengtao, W. U., Dong, P., & Tang, B. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.611201 · Cited by 39
Wang, S.-P., Iwata, S., Nakayamada, S., Niiro, H., Jabbarzadeh‐Tabrizi, S., Kondo, M., Kubo, S., Yoshikawa, M., & Tanaka, Y. (2015) · Rheumatology · doi:10.1093/rheumatology/keu532 · Cited by 39
HLA-DRB1 gene transcripts in rheumatoid arthritis
Candon, S., Combe, B. G., Vincent, R., Clot, J., Pinet, V., & Eliaou, J. F. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01498.x · Cited by 39
Xuan, W., Feng, X., Qian, C., Peng, L., Shi, Y., Xu, L., Wang, F., & Tan, W. (2017) · Cell Biochemistry and Function · doi:10.1002/cbf.3260 · Cited by 39
Andersen, G. B., & Tost, J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7481-8_1 · Cited by 39
Peficitinib for the treatment of rheumatoid arthritis: an overview from clinical trials
Tanaka, Y., & Izutsu, H. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1739649 · Cited by 39
Treatment of collagen-induced arthritis rat model by using Notch signalling inhibitor
Chen, J., Li, J., Chen, J., Cheng, W., Lin, J., Ke, L., Liu, G., Bai, X., & Zhang, P. (2021) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2021.01.003 · Cited by 39
Kanai, T., Kondo, N., Okada, M., Sano, H., Okumura, G., Kijima, Y., Ogose, A., Kawashima, H., & Endo, N. (2020) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-020-01595-9 · Cited by 38
Tofacitinib for the treatment of rheumatoid arthritis: an update
Yamaoka, K. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1607298 · Cited by 37
Galloway, J. B., Capron, J.-P., Leonardis, F. D., Fakhouri, W., Rose, A. L., Kouris, I., & Burke, T. (2020) · Rheumatology Advances in Practice · doi:10.1093/rap/rkaa041 · Cited by 37
Kosmaczewska, A., Świerkot, J., Ciszak, L., & Wiland, P. (2011) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.948971 · Cited by 36
SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases
Wu, W., Wang, J., Xiao, C., Su, Z., Su, H., Zhong, W., Mao, J., Liu, X., & Zhu, Y. Z. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.591 · Cited by 35
Self-citationLi, M., Hu, W., Wang, R., Li, Z., Yu, Y., Zhuo, Y., Zhang, Y., Wang, Z., Qiu, Y., Chen, K., et al. (2022) · Antioxidants · doi:10.3390/antiox11040732 · Cited by 35
Self-citationBöhm, I. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.04.010 · Cited by 33
Araki, Y., Aizaki, Y., Sato, K., Oda, H., Kurokawa, R., & Mimura, T. (2018) · PubMed · Cited by 33
Jiao, Z., Wang, W., Xu, H., Wang, S., Guo, M., Chen, Y., & Gao, J. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04310.x · Cited by 32
Autoimmune Connective Tissue Diseases: Systemic Lupus Erythematosus and Rheumatoid Arthritis
Rose, J. (2021) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2021.09.003 · Cited by 32
Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis
Krasselt, M., & Baerwald, C. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s87792 · Cited by 31
E2F1 mediates the downregulation of POLD1 in replicative senescence
Gao, S., Song, Q., Liu, J., Zhang, X., Ji, X., & Wang, P. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03070-z · Cited by 31
Bergström, B., Lundqvist, C., Vasileiadis, G. K., Carlsten, H., Ekwall, O., & Ekwall, A. H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01384 · Cited by 31
Pharmacogenetics of Etanercept in Rheumatoid Arthritis
Danila, M. I., Hughes, L. B., & Bridges, S. L. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.8.1011 · Cited by 30
HLA-DR and the Development of Rheumatoid Arthritis
Auger, I., & Roudier, J. (1997) · Autoimmunity · doi:10.3109/08916939709003856 · Cited by 30
Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
Li, J., Mao, H., Liang, Y., Lu, Y., Chen, S., Nan-ping, Y., & Shi, G. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/310628 · Cited by 30
Forefoot Deformity in Rheumatoid Arthritis: A Comparison of Shod and Unshod Populations
Dave, M., Mason, L. W., & Hariharan, K. (2015) · Foot & Ankle Specialist · doi:10.1177/1938640015583513 · Cited by 28
Notch receptors and ligands in inflammatory arthritis – a systematic review
Šućur, A., Filipović, M., Flegar, D., Kelava, T., Šisl, D., Lukač, N., Kovačić, N., & Grčević, D. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.04.010 · Cited by 27
Attentional function in fibromyalgia and rheumatoid arthritis
Galvez-Sánchez, C. M., de la Coba, P., Colmenero, J. M., del Paso, G. A. R., & Duschek, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246128 · Cited by 27
Emerging epigenetic targets in rheumatoid arthritis
Barik, R. R., & Bhatt, L. K. (2021) · Rheumatology International · doi:10.1007/s00296-021-04951-y · Cited by 27
Family-based association analysis of NAV2 gene with the risk and age at onset of Alzheimer's disease
Wang, K.-S., Liu, Y., Xu, C. D., Liu, X., & Luο, X. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.06.010 · Cited by 26
Perdigones, N., Vigo, A., Lamas, J. R., Martínez, A., Balsa, A., Pascual‐Salcedo, D., de la Concha, E. G., Fernández‐Gutiérrez, B., & Urcelay, E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27292 · Cited by 25
Infliximab: A Pharmacoeconomic Review of its Use in Rheumatoid Arthritis
Lyseng-Williamson, K. A., & Foster, R. H. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422020-00004 · Cited by 25
Lin, Y.-P., Su, C.-C., Huang, J.-Y., Lin, H.-C., Cheng, Y.-J., Liu, M.-F., & Yang, B.-C. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.07.021 · Cited by 24
Yu, Y., Wang, Z., Ding, Q., Yu, X., Yang, Q., Wang, R., Fang, Y., Qi, W., Liao, J., Hu, W., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050742 · Cited by 24
Self-citationNozaki, Y. (2021) · Life · doi:10.3390/life11050457 · Cited by 24
BTK Inhibitors in Chronic Lymphocytic Leukemia
Gaballa, S. R., & Pinilla-Ibarz, J. A. (2021) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-021-00645-1 · Cited by 23
Schellekens, G. A., Jong, B. A. W. D., van den Hoogen, F. H. J., Putte, L. B. A. V. D., & VENROOIJ, W. J. V. (2015) · PubMed · Cited by 22
Petralia, M. C., Mazzon, E., Basile, M. S., Cutuli, M. A., Marco, R. D., Scandurra, F., Saraceno, A., Fagone, P., Nicoletti, F., & Mangano, K. (2019) · Pharmaceuticals · doi:10.3390/ph12040174 · Cited by 22
Sarilumab: patient-reported outcomes in rheumatoid arthritis
Crotti, C., Biggioggero, M., Becciolini, A., & Favalli, E. G. (2018) · Patient Related Outcome Measures · doi:10.2147/prom.s147286 · Cited by 21
Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis
Wei, M., & Chu, C. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2021.101741 · Cited by 21
▼Tocilizumab for rheumatoid arthritis
BMJ Publishing Group Ltd (2009) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2009.08.0033 · Cited by 21
Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo
Abdou, A. G., Maraee, A. H., Yassien, H., & Sarhan, M. (2018) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2018.09.18 · Cited by 20
Wang, R., Li, M., Wu, W., Qiu, Y., Hu, W., Li, Z., Wang, Z., Yu, Y., Liao, J., Sun, W., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.376 · Cited by 20
Self-citationYu, Y., Wang, Z., Yang, Q., Ding, Q., Wang, R., Li, Z., Fang, Y., Liao, J., Qi, W., Chen, K., et al. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1921075 · Cited by 20
Self-citationUnique properties of TCR-activated p38 are necessary for NFAT-dependent T-cell activation
Alam, M. S., Gaida, M. M., Debnath, S., Tagad, H. D., Jenkins, L. M. M., Appella, E., Rahman, M. J., & Ashwell, J. D. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2004111 · Cited by 19
PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis
Kim, J., Jung, K. H., Yoo, J.-H., Park, J. H., YAN, H. H., Fang, Z., Lim, J. H., Kwon, S., Kim, M. K., Park, H., et al. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2019.153 · Cited by 19
Porchas-Quijada, M., Reyes-Castillo, Z., Muñóz-Valle, J. F., Duran-Barragán, S., Cervantes, V. G. A., López-Espinoza, A., Mercado, M. V.-D., Navarro-Meza, M., & López-Uriarte, P. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00252 · Cited by 17
Terazawa, S., Takada, M., Sato, Y., Nakajima, H., & Imokawa, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042057 · Cited by 17
The pathogenic role of ACPA in rheumatoid arthritis
Umeda, N., Matsumoto, I., & Sumida, T. (2017) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.40.391 · Cited by 15
Kargbo, R. B. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00245 · Cited by 14
Jevtič, V., & Lingg, G. M. (2012) · Handchirurgie · Mikrochirurgie · Plastische Chirurgie · doi:10.1055/s-0032-1321760 · Cited by 12
Evaluating filgotinib for the treatment of rheumatoid arthritis
Richez, C., & Truchetet, M. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1967929 · Cited by 10
Mok, C. C. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0548-0 · Cited by 9
Sutton, L. B. (1996) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)30151-6 · Cited by 8
Cell-Specific Epigenetic Drivers of Pathogenesis in Rheumatoid Arthritis
Nair, N., Barton, A. C., & Wilson, A. G. (2021) · Epigenomics · doi:10.2217/epi-2020-0380 · Cited by 7
Boeth, H., Biesen, R., Hollnagel, J., et al. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab323 · Cited by 7
Shavlovskaya, O. A., Бокова, И. А., & Shavlovskiy, N. I. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212201136 · Cited by 6
Davis, J. M. (2022) · The Journal of Rheumatology · doi:10.3899/jrheum.220412 · Cited by 5
Peptidylarginine deiminase type4 (PADI4) role in immune system
Seri, Y., Shoda, H., Matsumoto, I., Sumida, T., Fujio, K., & Yamamoto, K. (2014) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.37.154 · Cited by 4
Advances in the pathogenesis and treatment of autoimmunity
Moudgil, K. D. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.04.005 · Cited by 2
Cited by
Neutrophil extracellular traps in homeostasis and disease
Wang, H., Kim, S. J., Lei, Y., Wang, S., Wang, H., Huang, H., Zhang, H., & Tsung, A. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01933-x · Cited by 537
Song, Y., Li, J., & Wu, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01952-8 · Cited by 259
Metadata
- Authors
- Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2023-02-17
- Volume
- 8
- Issue
- 1
- Pages
- 68-68
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4321166025
- Cited by
- 478
- References
- 397
- FWCI
- 82.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.